The Consultant Pharmacist

IN THIS ISSUE

February 2017 | Volume 32 | Number 2

Leveraging Technology for Innovation

Editor-in-Chief, H. Edward Davidson, PharmD, MPH, gives a brief commentary on this issue of the journal and current new items of interest to consultant pharmacists.

Long-Term Care: Safe Drug Handling of Oral Chemotherapy

Many oral chemotherapy agents have been approved over the last 15 years, and they are displacing or augmenting parenteral chemotherapy. As more elders migrate to long-term care and assisted living facilities, consultant pharmacists may need to manage chemotherapy for the first time. Hazardous drug-handling recommendations provide a comprehensive approach.

Use of Telemedicine to Enhance Pharmacist Services in the Nursing Facility

The use of telemedicine in the nursing facility appears to improve patient outcomes and reduce costs. Telemedicine may be a resource efficient approach to enhance pharmacist services in the nursing facility and improve resident care. However, with the lack of studies in this area, there is a need for an evidence base from practice related research to demonstrate these potential benefits.

Incorporation of Herbal Supplements into a Pharmacogenomic Medication Therapy Management Practice

This article is the first report describing a medication therapy management (MTM) pharmacotherapy service that specializes in pharmacogenomic counseling, specifically geared toward identifying implications of dietary and herbal supplements. Offering a pharmacogenomic MTM service that specializes, provides patients with education on the safe use of these substances based on their genetic factors.

Sliding-Scale Insulin Use in Long-Term Care: An Updated Perspective

The most commonly prescribed insulin therapy for patients in long-term care is sliding-scale insulin (SSI), the use of finger-stick blood glucose testing to assess the need for insulin administration based on current blood glucose levels. Its sole use for long-term treatment is specifically not recommended. This review discusses recent updates to several published guidelines regarding the use of SSI-only insulin regimens for elderly patients in long-term care.

Do Restrictions on Antipsychotic Use Differ Between Medicare Part D Stand-Alone Versus Medicare Advantage Plans?

The findings from this study provide a preliminary look on the various types of restrictions seen, and the differences among, Medicare Part D plan design. Stand-alone prescription drug plan enrollees who were prescribed antipsychotics were more likely to face formulary restrictions, as opposed to those in Medicare Advantage prescription drug plans. In addition, low-income subsidy beneficiaries faced much higher risk of restricted access to antipsychotics.

HIGHLIGHTS FROM THE 2016 ANNUAL MEETING

Insights for consultant pharmacists from the 2016 Annual Meeting & Exhibition November 4-6, 2016, Dallas, Texas.

The Importance of Early Grassroots on Policy

An update on health care policy from ASCP's director of policy and advocacy.

READ THE JOURNAL

The Consultant Pharmacist® is the official monthly peer-reviewed journal of the American Society of Consultant Pharmacists (ASCP). It is the only journal dedicated exclusively to the medication therapy needs of seniors. ASCP members receive The Consultant Pharmacist® as a member benefit. All articles (2004 to present) are free online for members.




Nonmembers can access online abstracts to journal articles. Full articles are available for $35.00 each.


Content can be tailored and customized to fit your marketing and promotional needs and can be delivered via print or electronic format. For more information, contact:
Matt Neiderer
Matt.neiderer@sheridan.com
800-635-7181 ext. 8265


Editorial Office
H. Edward Davidson, PharmD, MPH
Insight Therapeutics, LLC
142 W. York Street, Suite 605
Norfolk, VA 23510
757-625-6040; Fax 757-625-4538
edavidson@inther.com


Individual Subscriptions
Individuals who want to receive access to The Consultant Pharmacist but are prohibited from joining the Society, can now subscribe to the journal. Subscription options include print and online combo, print-only, and online-only.
Subscribe as an Individual

Institutions and Libraries
Libraries or other institutions may receive unlimited access to the journal both in print and online for $405 annually. Online only is available for $305 annually. Pay-per-view, individual articles ordered from the online version only, are $35 per article. Single issues of previous years are offered for sale subject to availability at $55. Subscription rates are in U.S. dollars and are subject to change.
Subscribe as an Institution

The American Society of Consultant Pharmacists (ASCP)
1321 Duke Street, Alexandria, VA 22314
© 2016-2017 ASCP | Contact Us | Privacy Policy
ASCP Foundation | BCGP